In CSF, irisin levels correlated with several biomarkers of AD pathology, including a positive correlation with CSF Aβ42 (indicative of lower central nervous system amyloid burden), a positive association with BDNF, and a negative trend with total tau (t-tau) [ 77 , 92 ].
1
—
—